Refractory Autoimmune Hepatitis: Beyond Standard Therapy

作者: Jonah N. Rubin , Helen S. Te

DOI: 10.1007/S10620-015-4022-0

关键词:

摘要: Autoimmune hepatitis (AIH) can be difficult to control, particularly in some African-Americans. When standard therapy of prednisone and azathioprine is ineffective or poorly tolerated, alternative therapies are resorted to. We report two patients with AIH who were refractory intolerant therapy. They initially responded a combination tacrolimus MMF, but eventually developed acute flares the disease that had managed sirolimus, one case, rituximab, achieve remission.

参考文章(37)
Kelly W Burak, Mark G Swain, Tania Santodomino-Garzon, Samuel S Lee, Stefan J Urbanski, Alexander I Aspinall, Carla S Coffin, Robert P Myers, None, Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. Canadian Journal of Gastroenterology & Hepatology. ,vol. 27, pp. 273- 280 ,(2013) , 10.1155/2013/512624
Kareem Abu-Elmagd, W. Irish, P. Carroll, D. H. Van Thiel, H. Rodriguez-Rilo, J. Mcmichael, T. E. Starzl, H. Wright, Tacrolimus: A Potential New Treatment for Autoimmune Chronic Active Hepatitis: Results of an Open-Label Preliminary Trial The American Journal of Gastroenterology. ,vol. 90, pp. 771- 776 ,(1995) , 10.1111/J.1572-0241.1995.TB09317.X
Jeanette H W Leusen, Peter Boross, Mechanisms of action of CD20 antibodies American Journal of Cancer Research. ,vol. 2, pp. 676- 690 ,(2012)
Kaveh Sharzehi, Mary Ann Huang, Ian R Schreibman, Kimberly A Brown, Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Canadian Journal of Gastroenterology & Hepatology. ,vol. 24, pp. 588- 592 ,(2010) , 10.1155/2010/891252
Reza Malekzadeh, Siavosh Nasseri-Moghaddam, Mohammad-javad Kaviani, Hassan Taheri, Nasser Kamalian, Masoud Sotoudeh, Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Digestive Diseases and Sciences. ,vol. 46, pp. 1321- 1327 ,(2001) , 10.1023/A:1010683817344
M. M. Tannous, J. Cheng, K. Muniyappa, I. Farooq, A. Bharara, M. Kappus, V. Luketic, R. T. Stravtiz, M. Fuchs, P. Puri, A. Sanyal, R. Sterling, Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience. Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 405- 407 ,(2011) , 10.1111/J.1365-2036.2011.04749.X
A. M. C. Baven-Pronk, M. J. Coenraad, H. R. van Buuren, R. A. de Man, K. J. van Erpecum, M. M. H. Lamers, J. P. H. Drenth, A. P. van den Berg, U. H. Beuers, J. den Ouden, G. H. Koek, C. M. J. van Nieuwkerk, G. Bouma, J. T. Brouwer, B. van Hoek, The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 335- 343 ,(2011) , 10.1111/J.1365-2036.2011.04727.X
AP Trouvin, S Jacquot, S Grigioni, E Curis, I Dedreux, A Roucheux, H Boulard, O Vittecoq, X Le Loët, O Boyer, V Goëb, None, Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study. Clinical and Experimental Immunology. ,vol. 180, pp. 11- 18 ,(2015) , 10.1111/CEI.12481
Jacob Kurowski, Hector Melin-Aldana, Lee Bass, Estella M. Alonso, Udeme D. Ekong, Sirolimus as rescue therapy in pediatric autoimmune hepatitis Journal of Pediatric Gastroenterology and Nutrition. ,vol. 58, ,(2014) , 10.1097/MPG.0B013E318291FEAA
Elke M. Hennes, Ye H. Oo, Christoph Schramm, Ulrike Denzer, Peter Buggisch, Christiane Wiegard, Stephan Kanzler, Marcus Schuchmann, Wulf Boecher, Peter R. Galle, David H. Adams, Ansgar W. Lohse, Mycophenolate mofetil as second line therapy in autoimmune hepatitis The American Journal of Gastroenterology. ,vol. 103, pp. 3063- 3070 ,(2008) , 10.1111/J.1572-0241.2008.02180.X